ID   GALK1_HUMAN             Reviewed;         392 AA.
AC   P51570; B2RC07; B4E1G6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   15-MAR-2017, entry version 174.
DE   RecName: Full=Galactokinase;
DE            EC=2.7.1.6;
DE   AltName: Full=Galactose kinase;
GN   Name=GALK1; Synonyms=GALK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT II GALACTOSEMIA
RP   MET-32.
RX   PubMed=7670469; DOI=10.1038/ng0795-307;
RA   Stambolian D., Ai Y., Sidjanin D., Nesburn K., Sathe G., Rosenberg M.,
RA   Bergsma D.J.;
RT   "Cloning of the galactokinase cDNA and identification of mutations in
RT   two families with cataracts.";
RL   Nat. Genet. 10:307-312(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8908517; DOI=10.1101/gr.6.10.980;
RA   Bergsma D.J., Ai Y., Skach W.R., Nesburn K., Anoia E., van Horn S.,
RA   Stambolian D.;
RT   "Fine structure of the human galactokinase GALK1 gene.";
RL   Genome Res. 6:980-985(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 6-17; 22-37; 70-97; 205-239; 257-267; 288-296 AND
RP   343-388, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=7542884; DOI=10.1006/bbrc.1995.2023;
RA   Ai Y., Basu M., Bergsma D.J., Stambolian D.;
RT   "Comparison of the enzymatic activities of human galactokinase GALK1
RT   and a related human galactokinase protein GK2.";
RL   Biochem. Biophys. Res. Commun. 212:687-691(1995).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2-392 IN COMPLEX WITH
RP   D-GALACTOSE AND ATP ANALOG, SUBUNIT, AND SUBSTRATE-BINDING SITES.
RX   PubMed=15590630; DOI=10.1074/jbc.M412916200;
RA   Thoden J.B., Timson D.J., Reece R.J., Holden H.M.;
RT   "Molecular structure of human galactokinase: implications for type II
RT   galactosemia.";
RL   J. Biol. Chem. 280:9662-9670(2005).
RN   [14]
RP   VARIANT GALCT2 THR-28.
RX   PubMed=10521295; DOI=10.1086/302611;
RA   Kalaydjieva L., Perez-Lezaun A., Angelicheva D., Onengut S., Dye D.,
RA   Bosshard N.U., Jordanova A., Savov A., Yanakiev P., Kremensky I.,
RA   Radeva B., Hallmayer J., Markov A., Nedkova V., Tournev I., Aneva L.,
RA   Gitzelmann R.;
RT   "A founder mutation in the GK1 gene is responsible for galactokinase
RT   deficiency in Roma (Gypsies).";
RL   Am. J. Hum. Genet. 65:1299-1307(1999).
RN   [15]
RP   VARIANTS GALCT2 THR-28; ARG-36; TYR-44; SER-346 AND SER-349.
RX   PubMed=10790206;
RX   DOI=10.1002/(SICI)1098-1004(200005)15:5<447::AID-HUMU6>3.3.CO;2-D;
RA   Kolosha V., Anoia E., de Cespedes C., Gitzelmann R., Shih L.,
RA   Casco T., Saborio M., Trejos R., Buist N., Tedesco T., Skach W.,
RA   Mitelmann O., Ledee D., Huang K., Stambolian D.;
RT   "Novel mutations in 13 probands with galactokinase deficiency.";
RL   Hum. Mutat. 15:447-453(2000).
RN   [16]
RP   VARIANT GALCT2 VAL-198.
RX   PubMed=11231902; DOI=10.1086/319512;
RA   Okano Y., Asada M., Fujimoto A., Ohtake A., Murayama K., Hsiao K.-J.,
RA   Choeh K., Yang Y., Cao Q., Reichardt J.K.V., Niihira S., Imamura T.,
RA   Yamano T.;
RT   "A genetic factor for age-related cataract: identification and
RT   characterization of a novel galactokinase variant, 'Osaka,' in
RT   Asians.";
RL   Am. J. Hum. Genet. 68:1036-1042(2001).
RN   [17]
RP   VARIANTS GALCT2 CYS-68; MET-288 AND PRO-384.
RX   PubMed=11139256;
RX   DOI=10.1002/1098-1004(2001)17:1<77::AID-HUMU20>3.3.CO;2-8;
RA   Hunter M., Angelicheva D., Levy H.L., Pueschel S.M., Kalaydjieva L.;
RT   "Novel mutations in the GALK1 gene in patients with galactokinase
RT   deficiency.";
RL   Hum. Mutat. 17:77-78(2001).
RN   [18]
RP   CHARACTERIZATION OF VARIANTS GALCT2 THR-28; MET-32; ARG-36; TYR-44;
RP   CYS-68; VAL-198; MET-288; SER-346; SER-349 AND PRO-384.
RX   PubMed=12694189; DOI=10.1046/j.1432-1033.2003.03538.x;
RA   Timson D.J., Reece R.J.;
RT   "Functional analysis of disease-causing mutations in human
RT   galactokinase.";
RL   Eur. J. Biochem. 270:1767-1774(2003).
RN   [19]
RP   VARIANTS MET-184; ASP-274 AND ALA-338.
RX   PubMed=12942049;
RA   Maraini G., Hejtmancik J.F., Shiels A., Mackay D.S., Aldigeri R.,
RA   Jiao X.D., Williams S.L., Sperduto R.D., Reed G.;
RT   "Galactokinase gene mutations and age-related cataract. Lack of
RT   association in an Italian population.";
RL   Mol. Vis. 9:397-400(2003).
RN   [20]
RP   VARIANTS GALCT2 MET-32 AND GLN-239.
RX   PubMed=15024738; DOI=10.1002/humu.9223;
RA   Sangiuolo F., Magnani M., Stambolian D., Novelli G.;
RT   "Biochemical characterization of two GALK1 mutations in patients with
RT   galactokinase deficiency.";
RL   Hum. Mutat. 23:396-396(2004).
CC   -!- FUNCTION: Major enzyme for galactose metabolism.
CC   -!- CATALYTIC ACTIVITY: ATP + alpha-D-galactose = ADP + alpha-D-
CC       galactose 1-phosphate.
CC   -!- PATHWAY: Carbohydrate metabolism; galactose metabolism.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:15590630}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51570-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51570-2; Sequence=VSP_055079;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Galactosemia II (GALCT2) [MIM:230200]: Autosomal
CC       recessive deficiency characterized by congenital cataracts during
CC       infancy and presenile cataracts in the adult population. The
CC       cataracts are secondary to accumulation of galactitol in the
CC       lenses. {ECO:0000269|PubMed:10521295, ECO:0000269|PubMed:10790206,
CC       ECO:0000269|PubMed:11139256, ECO:0000269|PubMed:11231902,
CC       ECO:0000269|PubMed:12694189, ECO:0000269|PubMed:15024738}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the GHMP kinase family. GalK subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U26401; AAA96147.1; -; mRNA.
DR   EMBL; L76927; AAB51607.1; -; Genomic_DNA.
DR   EMBL; AK303832; BAG64778.1; -; mRNA.
DR   EMBL; AK314890; BAG37404.1; -; mRNA.
DR   EMBL; BT007005; AAP35651.1; -; mRNA.
DR   EMBL; AC087749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89316.1; -; Genomic_DNA.
DR   EMBL; BC001166; AAH01166.1; -; mRNA.
DR   CCDS; CCDS11728.1; -. [P51570-1]
DR   RefSeq; NP_000145.1; NM_000154.1. [P51570-1]
DR   UniGene; Hs.407966; -.
DR   PDB; 1WUU; X-ray; 2.50 A; A/B/C/D=2-392.
DR   PDB; 1YH7; Model; -; A=1-392.
DR   PDBsum; 1WUU; -.
DR   PDBsum; 1YH7; -.
DR   ProteinModelPortal; P51570; -.
DR   SMR; P51570; -.
DR   BioGrid; 108857; 16.
DR   IntAct; P51570; 16.
DR   MINT; MINT-4999410; -.
DR   STRING; 9606.ENSP00000225614; -.
DR   BindingDB; P51570; -.
DR   ChEMBL; CHEMBL1293257; -.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   iPTMnet; P51570; -.
DR   PhosphoSitePlus; P51570; -.
DR   BioMuta; GALK1; -.
DR   DMDM; 1730187; -.
DR   OGP; P51570; -.
DR   REPRODUCTION-2DPAGE; IPI00019383; -.
DR   EPD; P51570; -.
DR   PaxDb; P51570; -.
DR   PeptideAtlas; P51570; -.
DR   PRIDE; P51570; -.
DR   DNASU; 2584; -.
DR   Ensembl; ENST00000225614; ENSP00000225614; ENSG00000108479. [P51570-1]
DR   Ensembl; ENST00000588479; ENSP00000465930; ENSG00000108479. [P51570-1]
DR   GeneID; 2584; -.
DR   KEGG; hsa:2584; -.
DR   CTD; 2584; -.
DR   DisGeNET; 2584; -.
DR   GeneCards; GALK1; -.
DR   HGNC; HGNC:4118; GALK1.
DR   HPA; HPA007094; -.
DR   HPA; HPA016960; -.
DR   MalaCards; GALK1; -.
DR   MIM; 230200; phenotype.
DR   MIM; 604313; gene.
DR   neXtProt; NX_P51570; -.
DR   OpenTargets; ENSG00000108479; -.
DR   Orphanet; 79237; Galactokinase deficiency.
DR   PharmGKB; PA28533; -.
DR   eggNOG; KOG0631; Eukaryota.
DR   eggNOG; COG0153; LUCA.
DR   GeneTree; ENSGT00530000063433; -.
DR   HOGENOM; HOG000241100; -.
DR   HOVERGEN; HBG051695; -.
DR   InParanoid; P51570; -.
DR   KO; K00849; -.
DR   OMA; RREECAQ; -.
DR   OrthoDB; EOG091G06HT; -.
DR   PhylomeDB; P51570; -.
DR   TreeFam; TF354326; -.
DR   BRENDA; 2.7.1.6; 2681.
DR   Reactome; R-HSA-70370; Galactose catabolism.
DR   SABIO-RK; P51570; -.
DR   UniPathway; UPA00214; -.
DR   EvolutionaryTrace; P51570; -.
DR   GenomeRNAi; 2584; -.
DR   PRO; PR:P51570; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108479; -.
DR   CleanEx; HS_GALK1; -.
DR   ExpressionAtlas; P51570; baseline and differential.
DR   Genevisible; P51570; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004335; F:galactokinase activity; IDA:UniProtKB.
DR   GO; GO:0005534; F:galactose binding; IDA:UniProtKB.
DR   GO; GO:0019402; P:galactitol metabolic process; IEA:Ensembl.
DR   GO; GO:0019388; P:galactose catabolic process; TAS:Reactome.
DR   GO; GO:0006012; P:galactose metabolic process; IMP:UniProtKB.
DR   GO; GO:0061623; P:glycolytic process from galactose; IEA:Ensembl.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.70.890; -; 1.
DR   InterPro; IPR000705; Galactokinase.
DR   InterPro; IPR019741; Galactokinase_CS.
DR   InterPro; IPR019539; GalKase_gal-bd.
DR   InterPro; IPR013750; GHMP_kinase_C_dom.
DR   InterPro; IPR006204; GHMP_kinase_N_dom.
DR   InterPro; IPR006203; GHMP_knse_ATP-bd_CS.
DR   InterPro; IPR006206; Mevalonate/galactokinase.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10457:SF17; PTHR10457:SF17; 1.
DR   Pfam; PF10509; GalKase_gal_bdg; 1.
DR   Pfam; PF08544; GHMP_kinases_C; 1.
DR   Pfam; PF00288; GHMP_kinases_N; 1.
DR   PIRSF; PIRSF000530; Galactokinase; 1.
DR   PRINTS; PR00473; GALCTOKINASE.
DR   PRINTS; PR00959; MEVGALKINASE.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55060; SSF55060; 1.
DR   TIGRFAMs; TIGR00131; gal_kin; 1.
DR   PROSITE; PS00106; GALACTOKINASE; 1.
DR   PROSITE; PS00627; GHMP_KINASES_ATP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Carbohydrate metabolism; Cataract; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Galactose metabolism;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    392       Galactokinase.
FT                                /FTId=PRO_0000184645.
FT   NP_BIND     134    144       ATP.
FT   REGION       43     46       Substrate binding.
FT   REGION      183    186       Substrate binding.
FT   ACT_SITE    186    186       Proton acceptor. {ECO:0000250}.
FT   BINDING     236    236       Substrate.
FT   SITE         37     37       Transition state stabilizer.
FT                                {ECO:0000305}.
FT   MOD_RES     230    230       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1      1       M -> MCAPPRGAPPEHPAPTGLCRSSCAELQARVM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055079.
FT   VARIANT      28     28       P -> T (in GALCT2; founder Romani
FT                                mutation; dbSNP:rs104894572).
FT                                {ECO:0000269|PubMed:10521295,
FT                                ECO:0000269|PubMed:10790206,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_008514.
FT   VARIANT      32     32       V -> M (in GALCT2; dbSNP:rs104894576).
FT                                {ECO:0000269|PubMed:12694189,
FT                                ECO:0000269|PubMed:15024738,
FT                                ECO:0000269|PubMed:7670469}.
FT                                /FTId=VAR_002547.
FT   VARIANT      36     36       G -> R (in GALCT2).
FT                                {ECO:0000269|PubMed:10790206,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023486.
FT   VARIANT      44     44       H -> Y (in GALCT2).
FT                                {ECO:0000269|PubMed:10790206,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023487.
FT   VARIANT      68     68       R -> C (in GALCT2).
FT                                {ECO:0000269|PubMed:11139256,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023488.
FT   VARIANT     184    184       I -> M (in dbSNP:rs773416476).
FT                                {ECO:0000269|PubMed:12942049}.
FT                                /FTId=VAR_023489.
FT   VARIANT     198    198       A -> V (in GALCT2; mild deficiency;
FT                                Osaka; dbSNP:rs80084721).
FT                                {ECO:0000269|PubMed:11231902,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_015746.
FT   VARIANT     239    239       R -> Q (in GALCT2; dbSNP:rs575139300).
FT                                {ECO:0000269|PubMed:15024738}.
FT                                /FTId=VAR_023490.
FT   VARIANT     274    274       G -> D (in dbSNP:rs547925860).
FT                                {ECO:0000269|PubMed:12942049}.
FT                                /FTId=VAR_023491.
FT   VARIANT     288    288       T -> M (in GALCT2; dbSNP:rs759284637).
FT                                {ECO:0000269|PubMed:11139256,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023492.
FT   VARIANT     338    338       V -> A. {ECO:0000269|PubMed:12942049}.
FT                                /FTId=VAR_023493.
FT   VARIANT     346    346       G -> S (in GALCT2; dbSNP:rs375690568).
FT                                {ECO:0000269|PubMed:10790206,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023494.
FT   VARIANT     349    349       G -> S (in GALCT2; dbSNP:rs754967473).
FT                                {ECO:0000269|PubMed:10790206,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023495.
FT   VARIANT     384    384       A -> P (in GALCT2).
FT                                {ECO:0000269|PubMed:11139256,
FT                                ECO:0000269|PubMed:12694189}.
FT                                /FTId=VAR_023496.
FT   HELIX         9     24       {ECO:0000244|PDB:1WUU}.
FT   STRAND       29     41       {ECO:0000244|PDB:1WUU}.
FT   HELIX        46     48       {ECO:0000244|PDB:1WUU}.
FT   STRAND       51     68       {ECO:0000244|PDB:1WUU}.
FT   STRAND       72     77       {ECO:0000244|PDB:1WUU}.
FT   STRAND       80     82       {ECO:0000244|PDB:1WUU}.
FT   STRAND       86     91       {ECO:0000244|PDB:1WUU}.
FT   HELIX       105    107       {ECO:0000244|PDB:1WUU}.
FT   HELIX       108    116       {ECO:0000244|PDB:1WUU}.
FT   STRAND      118    120       {ECO:0000244|PDB:1WUU}.
FT   STRAND      124    131       {ECO:0000244|PDB:1WUU}.
FT   STRAND      137    139       {ECO:0000244|PDB:1WUU}.
FT   HELIX       141    156       {ECO:0000244|PDB:1WUU}.
FT   HELIX       163    176       {ECO:0000244|PDB:1WUU}.
FT   HELIX       185    192       {ECO:0000244|PDB:1WUU}.
FT   STRAND      197    202       {ECO:0000244|PDB:1WUU}.
FT   TURN        203    205       {ECO:0000244|PDB:1WUU}.
FT   STRAND      208    212       {ECO:0000244|PDB:1WUU}.
FT   STRAND      216    228       {ECO:0000244|PDB:1WUU}.
FT   TURN        233    235       {ECO:0000244|PDB:1WUU}.
FT   HELIX       236    249       {ECO:0000244|PDB:1WUU}.
FT   HELIX       260    263       {ECO:0000244|PDB:1WUU}.
FT   HELIX       266    269       {ECO:0000244|PDB:1WUU}.
FT   HELIX       272    296       {ECO:0000244|PDB:1WUU}.
FT   HELIX       300    316       {ECO:0000244|PDB:1WUU}.
FT   HELIX       323    333       {ECO:0000244|PDB:1WUU}.
FT   STRAND      338    343       {ECO:0000244|PDB:1WUU}.
FT   STRAND      348    357       {ECO:0000244|PDB:1WUU}.
FT   HELIX       358    360       {ECO:0000244|PDB:1WUU}.
FT   HELIX       361    371       {ECO:0000244|PDB:1WUU}.
FT   STRAND      377    381       {ECO:0000244|PDB:1WUU}.
FT   STRAND      387    389       {ECO:0000244|PDB:1WUU}.
SQ   SEQUENCE   392 AA;  42272 MW;  8D7CFF8FDB0E4718 CRC64;
     MAALRQPQVA ELLAEARRAF REEFGAEPEL AVSAPGRVNL IGEHTDYNQG LVLPMALELM
     TVLVGSPRKD GLVSLLTTSE GADEPQRLQF PLPTAQRSLE PGTPRWANYV KGVIQYYPAA
     PLPGFSAVVV SSVPLGGGLS SSASLEVATY TFLQQLCPDS GTIAARAQVC QQAEHSFAGM
     PCGIMDQFIS LMGQKGHALL IDCRSLETSL VPLSDPKLAV LITNSNVRHS LASSEYPVRR
     RQCEEVARAL GKESLREVQL EELEAARDLV SKEGFRRARH VVGEIRRTAQ AAAALRRGDY
     RAFGRLMVES HRSLRDDYEV SCPELDQLVE AALAVPGVYG SRMTGGGFGG CTVTLLEASA
     APHAMRHIQE HYGGTATFYL SQAADGAKVL CL
//
